CompanyAVXLNasdaqNew York, NY

Anavex Life Sciences Corp.

Anavex Life Sciences develops novel therapeutics for central nervous system diseases.

SEC EDGAR ClinicalTrials.gov anavex.com

8-KSep 28Latest SEC filing

Aug 25Latest story

August 2026

Anavex reports fiscal Q3 2026 results, updates progress on Alzheimer's, Rett, Fragile X programs

Aug 25Quarterly updateAnavex Life Sciences Corp.

July 2026

Anavex updates Alzheimer's regulatory strategy, reports Q2 fiscal 2026 results

Jul 30Quarterly updateAnavex Life Sciences Corp.